Cargando…
Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis
BACKGROUND: Cholestatic liver injury can lead to serious symptoms and prognoses in the clinic. Currently, an effective medical treatment is not available for cholestatic liver injury. Human menstrual blood-derived stem cells (MenSCs) are considered as an emerging treatment in various diseases. This...
Autores principales: | Yang, Ya, Chen, Yanfei, Zhao, Yalei, Ji, Feiyang, Zhang, Lingjian, Tang, Shima, Zhang, Sainan, Hu, Qingqing, Li, Zuhong, Zhang, Fen, Li, Qian, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817575/ https://www.ncbi.nlm.nih.gov/pubmed/35123555 http://dx.doi.org/10.1186/s13287-022-02734-1 |
Ejemplares similares
-
Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis
por: Zhang, Fen, et al.
Publicado: (2022) -
The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
por: Yang, Ya, et al.
Publicado: (2021) -
COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies
por: Yang, Ya, et al.
Publicado: (2020) -
1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022) -
Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure
por: Xiao, Lanlan, et al.
Publicado: (2021)